Skip to main content
Fig. 1 | The Journal of Headache and Pain

Fig. 1

From: Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study

Fig. 1

Distribution of acute medication optimization (mTOQ-4) at baseline and week 4. The mTOQ-4 was derived from the mTOQ-6 by selecting the items that best assessed efficacy: “2-h pain free,” “24-h relief,” “able to plan,” and “in control.” Each item is rated never (1), rarely (2), less than half the time (3), or half the time or more (4). Patients were grouped by baseline mTOQ-4 total scores into the following optimization categories: very poor (0), poor (1–5), moderate (6–7), and maximal (8). mTOQ-4/mTOQ-6, 4-item/6-item Migraine Treatment Optimization Questionnaire

Back to article page